TDF and Entekavir - Hepatitis B Reactivation

Viral Hepatitis Society10,000 enrolled

Overview

This is a non-interventional retrospective multi-center study for the patients received Entekavir or TDF for Hepatitis B prophylaxis.

Study Type

OBSERVATIONAL

Enrollment

10,000

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients used entekavir or TDF for Hepatitis B prophylaxis Exclusion Criteria: * Patients lower then 18 years old.

Cerrahpasa Medical Faculty

Istanbul, Turkey (Türkiye)

RECRUITING

Reactivation Rate

Percentage of patients reactivated during the Entekavir or TDF

Time frame: 12 months

Fehmi Tabak, Prof

CONTACT

Ilker Kurkcu

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.